PWM
MDT icon

Proathlete Wealth Management’s Medtronic MDT Stock Holding History

Proathlete Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-198
Closed -$18.9K – 318
2025
Q3 		$18.9K Hold
198
– – 0.01% 142
2025
Q2 		$17.3K Hold
198
– – 0.01% 160
2025
Q1 		$17.8K Buy
+198
New +$17.7K 0.01% 142

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Proathlete Wealth Management's MDT Position: Q4 2025 in Review

Proathlete Wealth Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 198 shares — an estimated $18.9K sold.

Proathlete Wealth Management first reported a position in MDT in Q1 2025 and held it in 3 quarters. The position peaked at $18.9K in Q3 2025. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Proathlete Wealth Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Proathlete Wealth Management sold 198 Medtronic shares in Q4 2025, an estimated $18.9K.
  • Proathlete Wealth Management first reported a position in Medtronic in Q1 2025 and held it in 3 quarters.
  • Proathlete Wealth Management's Medtronic position peaked at $18.9K in Q3 2025.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Proathlete Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.